AINU Chennai breaks barriers in urological care

HoLEP Procedure Marks Milestone Achievement on 75-Year-Old Patient with Abnormally Enlarged Prostate 

AINU Chennai breaks barriers in urological care

Chennai | January 4, 2024 : In a groundbreaking achievement, Asian Institute of Nephrology and Urology (AINU), a leading kidney care specialist in India & Chennai ’s largest nephrology and urology healthcare specialty center, has successfully treated a patient with an abnormally enlarged prostate. The revolutionary urological procedure, Holmium Laser Enucleation of the Prostate (HoLEP), was employed, utilizing state-of-the-art laser technology to remove obstructive tissue, leading to the patient's successful discharge within 2 days.

The patient, a 75-year-old male, presented a complex medical profile with co-morbidities including Diabetes Mellitus, Hypertension, and a three-year history of untreated Prostatomegaly (enlarged prostate), resulting in urinary retention problems. A pivotal MRI Prostate revealed the severity of the condition, indicating a significantly enlarged volume of 212.9cc, 10 times larger than normal, necessitating expert intervention. A skilled team of doctors, led by Dr.Arun Kumar B –Managing Director & Senior Consultant Urologist and Dr. Venkat Subramanium, Executive Director & Consultant Urologist at AINU, successfully performed the groundbreaking HoLEP procedure on the patient, marking a transformative milestone in urological therapy.

Dr. Arun Kumar B highlighted the significance of the hospital's accomplishment, stating, "Compared to the alternate conventional procedure TURP, the HoLEP procedure offers the advantage of handling large prostate volumes greater than 100 cc in a single sitting, with reduced bleeding, fewer repeated procedures, shorter catheterization times, fewer complications and most importantly quicker recovery time. Our commitment to excellence in patient care is evident in our adoption of HoLEP as the new gold standard, particularly beneficial for those with large prostates. It can be even used in cardiac patients where blood thinner cannot be stopped.Its efficacy, comparable to open prostatectomy but with significantly lower morbidity, marks a transformative milestone in urological therapy. Embracing HoLEP aligns with AINU's dedication to pushing the boundaries of medical innovation, ensuring our patients receive the most advanced and optimal treatments available." Prostate complications, particularly common in men over 50, can arise from various conditions affecting the prostate gland. AINU Chennai addresses these challenges through a range of procedures and treatments, including medications, TURP, HoLEP, and Uro-Lift, providing comprehensive care for patients with diverse urological conditions. This groundbreaking achievement reinforces AINU Chennai's commitment to pushing the boundaries of urological care and marks a significant milestone in the institution's ongoing mission to provide cutting-edge medical solutions focused on kidney care.